Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 27, 2016 06:00 ET | Source: Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Receives Complete Response Letter for Primatene® Mist

RANCHO CUCAMONGA, Calif., Dec. 27, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ:AMPH) announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response...
November 28, 2016 06:00 ET | Source: Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals to Present at the 2016 Piper Jaffray Healthcare Conference

RANCHO CUCAMONGA, Calif., Nov. 28, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President will be presenting at the 2016 Piper...
November 08, 2016 16:05 ET | Source: Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2016

Reports Net Revenues of $64.2 Million for the Three Months Ended September 30, 2016 RANCHO CUCAMONGA, Calif., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)...
October 28, 2016 06:00 ET | Source: Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2016

RANCHO CUCAMONGA, Calif., Oct. 28, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2016 ended...
September 01, 2016 06:00 ET | Source: Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals to Present at the 2016 Wells Fargo Healthcare Conference

RANCHO CUCAMONGA, Calif., Sept. 01, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President will be presenting at the 2016 Wells Fargo...
August 08, 2016 16:05 ET | Source: Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2016

RANCHO CUCAMONGA, Calif., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”) today reported results for the three months ended June 30,...
August 04, 2016 06:00 ET | Source: Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals, Inc. Purchases International Medication Systems (UK) Limited from UCB PHARMA GmbH

RANCHO CUCAMONGA, Calif., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”), announced today that, through its wholly owned UK...
August 01, 2016 06:00 ET | Source: Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2016

RANCHO CUCAMONGA, Calif., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2016 ended June...
June 03, 2016 06:00 ET | Source: Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals to Present at the Jefferies 2016 Healthcare Conference

RANCHO CUCAMONGA, Calif., June 03, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President will be presenting at the Jefferies 2016...
May 09, 2016 16:05 ET | Source: Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals Reports Financial Results for the First Quarter Ended March 31, 2016

RANCHO CUCAMONGA, Calif., May 09, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”) today reported results for the first quarter ended March 31,...